| Insider Name | Buy/Sell | Amount | Shares Change | |||
|---|---|---|---|---|---|---|
| Jun 06, 2022 | Jun 07, 2022 | Matthews Christine CFO | Sell | $0.71 | $58 | -1.92% |
| Jun 06, 2022 | Jun 07, 2022 | Lo Steven CEO | Sell | $0.71 | $314 | -3.25% |
| Mar 31, 2022 | Apr 02, 2022 | Matthews Christine CFO | Sell | $0.21 | $1,705 | -5.25% |
| Mar 31, 2022 | Apr 02, 2022 | Kellerman Donald J VP Clinical Dev Med Affairs | Sell | $0.21 | $842 | -6.64% |
| Mar 31, 2022 | Apr 02, 2022 | Lo Steven CEO | Sell | $0.21 | $4,965 | -4.88% |
| Nov 23, 2021 | Nov 24, 2021 | Greathouse Kenneth Dir | Sell | $0.6 | $6,018 | -18.69% |
| Jun 04, 2021 | Jun 07, 2021 | Lo Steven CEO | Sell | $0.81 | $10,592 | -3.47% |
| Jun 04, 2021 | Jun 07, 2021 | Lewis Hayley | Sell | $0.81 | $1,376 | -3.32% |
| Jun 04, 2021 | Jun 07, 2021 | Kellerman Donald J VP Clinical Dev Med Affairs | Sell | $0.81 | $1,376 | -3.28% |
| Jun 04, 2021 | Jun 07, 2021 | Matthews Christine CFO | Sell | $0.81 | $1,376 | -1.71% |
| Apr 11, 2019 | Apr 18, 2019 | Walker John Peter Pres CEO | Buy | $3.5 | $350,000 | +26.30% |
| Feb 26, 2018 | Feb 28, 2018 | Amzak Capital Management, LLC 10% | Sell | $8.4 | $741,174 | -33.50% |
| Dec 06, 2017 | Dec 08, 2017 | Greathouse Kenneth Dir | Buy | $0.61 | $33,407 | +21.57% |
| Nov 30, 2017 | Dec 04, 2017 | Greathouse Kenneth Dir | Buy | $0.62 | $59,007 | +39.58% |
| Nov 14, 2017 | Nov 16, 2017 | Greathouse Kenneth Dir | Buy | $0.62 | $31,159 | +50.00% |
| May 24, 2017 | May 26, 2017 | Walker John Peter Interim CEO | Buy | $1.36 | $99,891 | +26.27% |
| May 25, 2017 | May 26, 2017 | Erbez Georgia CFO Chief Business Officer | Buy | $1.32 | $89,760 | +37.01% |
| May 24, 2017 | May 26, 2017 | Walker John Peter Interim CEO | Buy | $1.36 | $99,891 | +26.27% |
| Sep 16, 2016 | Sep 20, 2016 | Barrett M James 10% | Sell | $0.75 | $5,603 | -0.36% |
| Sep 16, 2016 | Sep 20, 2016 | New Enterprise Associates 12, Limited Partnership 10% | Sell | $0.75 | $5,603 | -0.36% |
| Sep 13, 2016 | Sep 15, 2016 | Barrett M James 10% | Sell | $0.74 | $7,400 | -0.48% |
| Sep 13, 2016 | Sep 15, 2016 | New Enterprise Associates 12, Limited Partnership 10% | Sell | $0.74 | $7,400 | -0.48% |
| Aug 29, 2016 | Aug 31, 2016 | Barrett M James 10% | Sell | $1.01 | $50,440 | -2.36% |
| Aug 29, 2016 | Aug 31, 2016 | New Enterprise Associates 12, Limited Partnership 10% | Sell | $1.01 | $50,440 | -2.36% |
| Aug 24, 2016 | Aug 26, 2016 | Barrett M James 10% | Sell | $1.21 | $1,452 | -0.06% |
| Aug 24, 2016 | Aug 26, 2016 | New Enterprise Associates 12, Limited Partnership 10% | Sell | $1.21 | $1,452 | -0.06% |
| Aug 19, 2016 | Aug 22, 2016 | Erbez Georgia Interim CFO | Buy | $1.32 | $63,030 | +50.00% |
| Aug 19, 2016 | Aug 22, 2016 | Lewis Hayley VP Reg Affairs Quality | Buy | $1.32 | $6,303 | +50.00% |
| Aug 19, 2016 | Aug 22, 2016 | Kellerman Donald J VP Clinical Dev Med Affairs | Buy | $1.32 | $21,014 | +50.00% |
| Aug 19, 2016 | Aug 22, 2016 | Walker John Peter Dir | Buy | $1.32 | $84,084 | +50.00% |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.